Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
3(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
11%
Ph not_applicable
5
56%
Ph phase_1
1
11%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 3Large-scale testing
1(14.3%)
N/ANon-phased studies
5(71.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

3

trials recruiting

Total Trials

9

all time

Status Distribution
Active(5)
Completed(1)
Terminated(1)
Other(2)

Detailed Status

Recruiting3
unknown2
Not yet recruiting2
Completed1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (14.3%)
Phase 31 (14.3%)
N/A5 (71.4%)

Trials by Status

recruiting333%
unknown222%
completed111%
not_yet_recruiting222%
withdrawn111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
9